4//SEC Filing
BB BIOTECH AG 4
Accession 0001104659-25-026305
CIK 0001701541other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 9:01 PM ET
Size
15.6 KB
Accession
0001104659-25-026305
Insider Transaction Report
Form 4
BB BIOTECH AG
10% Owner
Transactions
- Sale
Common Stock
2025-03-19$1.94/sh−300,000$582,900→ 7,217,839 total - Sale
Common Stock
2025-03-19$2.07/sh−1,000,000$2,069,100→ 7,517,839 total - Sale
Common Stock
2025-03-19$2.09/sh−400,000$837,160→ 3,817,839 total - Sale
Common Stock
2025-03-19$1.95/sh−584,292$1,141,239→ 3,233,547 total - Sale
Common Stock
2025-03-19$2.31/sh−1,000,000$2,308,100→ 6,217,839 total - Sale
Common Stock
2025-03-19$2.00/sh−2,000,000$4,000,800→ 4,217,839 total - Sale
Common Stock
2025-03-19$2.12/sh−500,000$1,058,450→ 2,733,547 total
BIOTECH GROWTH N V
10% Owner
Transactions
- Sale
Common Stock
2025-03-19$1.95/sh−584,292$1,141,239→ 3,233,547 total - Sale
Common Stock
2025-03-19$2.07/sh−1,000,000$2,069,100→ 7,517,839 total - Sale
Common Stock
2025-03-19$1.94/sh−300,000$582,900→ 7,217,839 total - Sale
Common Stock
2025-03-19$2.31/sh−1,000,000$2,308,100→ 6,217,839 total - Sale
Common Stock
2025-03-19$2.00/sh−2,000,000$4,000,800→ 4,217,839 total - Sale
Common Stock
2025-03-19$2.09/sh−400,000$837,160→ 3,817,839 total - Sale
Common Stock
2025-03-19$2.12/sh−500,000$1,058,450→ 2,733,547 total
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0000924223
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 9:01 PM ET
- Size
- 15.6 KB